Last Coronavirus: Canada suspends use of AstraZeneca under-55 shooting
Canada has discontinued the Oxford / AstraZeneca coronavirus vaccine for younger adults “as a precautionary measure,” after concerns in Europe that shooting may be linked to rare blood clots.
National Inclusion Advisory Committee a statement on Monday he recommended the AstraZeneca vaccine “not to be used in adults under the age of 55 at this time,” while the role of the shot is being investigated in potential “rare cases of severe blood clots.”
Among the people who recently shot AstraZeneca in Europe, cases of these blood clots have been “mainly” in women under the age of 55, although there have been some cases of men, Naci said in a statement. “The rate of this adverse event has not yet been confirmed,” he said.
Supriya Sharma, chief medical adviser at Health Canada, told a news conference on Monday that authorities “do not yet have enough information” to say whether the risks outweigh the benefits to young adults, but for people aged 80 and over, “We see it working really well “.
The provinces of Canada, including the island of Manitoba and Prince Edward Island, said they would immediately discontinue the use of the AstraZeneca vaccine in younger adults.
Earlier this month, more than a dozen European countries paused or restricted the use of the AstraZeneca shot to the brain after a strange and severe combination of blood clots resulted in a low number of platelets and bleeding in a limited number of patients. Some patients died. The United Kingdom also registered some of these cases, but did not suspend or limit the use of the shot.
The European Medicines Agency looked at whether there was a link between shooting and the overall risk of blood clots, but determined that there was none. However, the regulator has left the door open for a possible link between the side effects and the unique combination of the vaccine. Surveillance continues, but most countries have resumed administering the jab.
The disruption dealt a severe blow to the European vaccination campaign against the disease, which is followed by the US and the UK. Throughout the crisis, the EMA and the World Health Organization reiterated that the benefits of the shot outweigh its potential risks, even as they demonstrate the link between rare and severe blood clots and the shot.
AstraZeneca stressed that its vaccine is safe and has been administered to millions of people around the world, with evidence showing that it is safe and effective from real clinical evidence around the world.